Experience
Elan Corp., PLC
Brightstone Pharma
Represented Elan in Hatch-Waxman litigation against Brightstone and SkyePharma relating to their intention to market generic copies of Naprelan®. Case settled on confidential terms.
Elan Corp., PLC v. Brightstone Pharma, 5:98-cv-00701, E.D.N.C., Judge Britt
A high-impact result for R&D licensing programs in the pharmaceutical industry
Elan Corporation PLC
Medtronic PLC
Wyeth
PQ Corp. v. Johnson Matthey PLC
PQ Corp.
Aventis Pharma, S.A. v. Baxter Healthcare Corp.
Aventis Pharma, S.A.
Synthon Pharmaceuticals, Inc. v. Eli Lilly and Co.
Eli Lilly and Co.; ICOS
Glenmark Generics Ltd. v. GlaxoSmithKline, PLC
GlaxoSmithKline, PLC
Drexler Technology Corp. v. Sony Corp.
Sony Corp.
Due to international data regulations, we’ve updated our privacy policy. Click here to read our privacy policy in full.